VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$1.27
+0.09 (+7.63%)
Financial Highlights (FY 2026)
Revenue
32.64M
Net Income
-24,181,138
Gross Margin
60.0%
Profit Margin
-74.1%
Rev Growth
-3.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.0% 60.0% 46.4% 46.4%
Operating Margin -74.3% -66.9% 21.5% 19.1%
Profit Margin -74.1% -70.4% 15.3% 15.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 32.64M 33.93M 4.42M 4.57M
Gross Profit 19.58M 20.36M 2.05M 2.12M
Operating Income -24,257,045 -22,696,060 949.1K 872.8K
Net Income -24,181,138 -22,625,038 675.6K 727.9K
Gross Margin 60.0% 60.0% 46.4% 46.4%
Operating Margin -74.3% -66.9% 21.5% 19.1%
Profit Margin -74.1% -70.4% 15.3% 15.9%
Rev Growth -3.8% -3.8% +3.6% -1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 6.54M 5.85M
Total Equity 8.58M 7.69M
D/E Ratio 0.76 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -22,918,888 -22,635,350 1.16M 1.26M
Free Cash Flow 869.0K 665.9K